Hologic is set for acquisition by alternative asset management entities Blackstone and TPG for up to $18.3bn in enterprise value, as part of a definitive agreement. The transaction is valued at a potential $79 per share. Stockholders of Hologic are poised to receive $76 per share in cash, with the possibility of an additional $3 per share through a contingent value right (CVR), which will be distributed in two potential payments of up to $1.50 each. The non-tradable CVR will be issued to the shareholder ...